Recent Quotes
My Watchlist
Indicators
Central Oregon Stock Index
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Lantheus Holdings, Inc. - Common Stock (NQ:LNTH)

103.04 +2.79 (+2.78%)
Streaming Delayed Price Updated: 10:18 AM EDT, Jun 4, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Lantheus Holdings, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9
...
12 13 Next >
News headline image
Why This Fund Cashed Out of a Stock That Soared 250% in Just One Year ↗
This energy services provider delivers drilling, technology, and equipment solutions to oil and gas clients across more than 20 countries. 
Via The Motley Fool
Topics Regulatory Compliance
News headline image
3 Hyped Up Stocks with Warning Signs
Great things are happening to the stocks in this article. They’re all outperforming the market over the last month because of positive catalysts such as a ne... 
Via StockStory
News headline image
Lantheus (LNTH) Q1 2026 Earnings Transcript ↗
Lantheus (LNTH) Q1 2026 Earnings Transcript 
Via The Motley Fool
Lantheus (NASDAQ:LNTH) Beats Q1 Estimates, Guides In Line, And Wall Street Is Paying Attention ↗
Via Chartmill
Lantheus Holdings (NASDAQ:LNTH): A Decent Value Pick in Diagnostic Imaging ↗
Via Chartmill
Lantheus Holdings Inc (NASDAQ:LNTH) Beats Q4 Estimates but 2026 Guidance Disappoints ↗
Via Chartmill
Lantheus Holdings Inc. (NASDAQ:LNTH) Presents a Compelling Value Investment Case ↗
Via Chartmill
News headline image
These Analysts Raise Their Forecasts On Lantheus After Upbeat Q1 Results ↗
Lantheus Holdings Inc (NASDAQ:LNTH) reported upbeat Q1 earnings, reaffirmed guidance, and received price target hikes from analysts. 
Via Benzinga
News headline image
Lantheus Q1 Earnings Call Highlights ↗
Lantheus (NASDAQ:LNTH) reported what management described as a strong start to 2026, citing solid performance from its three core commercial products—PYLARIFY, Neuraceq® and DEFINITY—and progress on... 
Via MarketBeat
Topics Earnings
News headline image
Lantheus (NASDAQ:LNTH) Surprises With Q1 CY2026 Sales
Radiopharmaceutical company Lantheus Holdings (NASDAQ:LNTH) reported Q1 CY2026 results topping the market’s revenue expectations, with sales up 1.2% year on ... 
Via StockStory
News headline image
Lantheus (LNTH) Q1 Earnings Report Preview: What To Look For
Radiopharmaceutical company Lantheus Holdings (NASDAQ:LNTH) will be reporting results this Thursday before the bell. Here’s what to look for. Lantheus beat a... 
Via StockStory
Lantheus Holdings Inc (NASDAQ:LNTH) Presents a Compelling Value Case with Strong Fundamentals ↗
Via Chartmill
News headline image
1 Healthcare Stock to Target This Week and 2 We Ignore
Healthcare companies are pushing the status quo by innovating in areas like drug development and digital health. Despite the rosy long-term prospects, short-... 
Via StockStory
News headline image
3 Profitable Stocks We Think Twice About
Even if a company is profitable, it doesn’t always mean it’s a great investment. Some struggle to maintain growth, face looming threats, or fail to reinvest ... 
Via StockStory
News headline image
3 Cash-Producing Stocks Walking a Fine Line
Generating cash is essential for any business, but not all cash-rich companies are great investments. Some produce plenty of cash but fail to allocate it eff... 
Via StockStory
News headline image
1 of Wall Street’s Favorite Stock for Long-Term Investors and 2 We Ignore
Wall Street is overwhelmingly bullish on the stocks in this article, with price targets suggesting significant upside potential. However, it’s worth remember... 
Via StockStory
News headline image
3 Russell 2000 Stocks We’re Skeptical Of
Small-cap stocks in the Russell 2000 (^RUT) can be a goldmine for investors looking beyond the usual large-cap names. But with less stability and fewer resou... 
Via StockStory
News headline image
Lantheus Says FDA Pushed Deadline For Reviewing Its Tumor Diagnostic Kit Application ↗
The agency is now slated to decide on the company’s application seeking approval for the diagnostic kit by June 29. 
Via Stocktwits
News headline image
3 Reasons to Sell LNTH and 1 Stock to Buy Instead
What a fantastic six months it’s been for Lantheus. Shares of the company have skyrocketed 57%, hitting $83.14. This run-up might have investors contemplatin... 
Via StockStory
Topics Supply Chain
News headline image
Q4 Earnings Highlights: Lantheus (NASDAQ:LNTH) Vs The Rest Of The Medical Devices & Supplies - Imaging, Diagnostics Stocks
Let’s dig into the relative performance of Lantheus (NASDAQ:LNTH) and its peers as we unravel the now-completed Q4 medical devices & supplies - imaging, diag... 
Via StockStory
Topics Artificial Intelligence
News headline image
Why Lantheus Holdings Stock Popped by Almost 12% Last Month ↗
Investors were clearly impressed by the medical device specialist's fourth-quarter performance. 
Via The Motley Fool
News headline image
Why Is LNTH Stock Up After Hours? ↗
Lantheus said that the FDA approved its PYLARIFY TruVu injection. 
Via Stocktwits
News headline image
Lantheus (LNTH) Q4 2025 Earnings Call Transcript ↗
Lantheus (LNTH) Q4 2025 Earnings Call Transcript 
Via The Motley Fool
Topics Earnings
News headline image
Lantheus (NASDAQ:LNTH) Exceeds Q4 CY2025 Expectations
Radiopharmaceutical company Lantheus Holdings (NASDAQ:LNTH) beat Wall Street’s revenue expectations in Q4 CY2025, with sales up 4% year on year to $406.8 million. On the other hand, the company’s... 
Via StockStory
News headline image
Lantheus Earnings: What To Look For From LNTH
Radiopharmaceutical company Lantheus Holdings (NASDAQ:LNTH) will be reporting earnings this Thursday before the bell. Here’s what to expect. 
Via StockStory
Topics Economy World Trade
News headline image
2 Value Stocks to Target This Week and 1 Facing Headwinds
The low valuation multiples for value stocks provide a margin of safety that growth stocks rarely offer. However, the challenge lies in determining whether these cheap assets are genuinely undervalued... 
Via StockStory
News headline image
2 Small-Cap Stocks Worth Investigating and 1 We Avoid
Investors looking for hidden gems should keep an eye on small-cap stocks because they’re frequently overlooked by Wall Street. Many opportunities exist in this part of the market, but it is also a... 
Via StockStory
News headline image
3 Market-Beating Stocks for Long-Term Investors
The best-performing stocks typically have robust sales growth, increasing margins, and rising returns on capital, and those that can maintain this trifecta year in and year out often become the legends... 
Via StockStory
News headline image
2 Healthcare Stocks for Long-Term Investors and 1 We Find Risky
Personal health and wellness is one of the many secular tailwinds for healthcare companies. Players catalyzing medical advancements have benefited from elevated demand, which has supported the... 
Via StockStory
Topics Stocks
News headline image
Lantheus Exit: $28 Million Sale Comes as Earnings Fall 77% Year Over Year ↗
The move suggests that shrinking margins, leadership turnover, and a shifting product mix are quietly reshaping the Lantheus investment case. 
Via The Motley Fool
Topics Regulatory Compliance Supply Chain
< Previous 1 2 3 4 5 6 7 8 9
...
12 13 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.